ArticleACS omega2025
The Preparation and Characterization of Electrospun Chitosan-Gelatin Nanofibers Containing Copper-Metal-Organic Frameworks Loaded with Curcumin and Chrysin as Antibacterial Wound Dressings.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cu-based metal-organic frameworks: synthesis, biomedical applications, and beyond.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An electrospun chitosan-gelatin (CS-GL) nanofiber encapsulated with the curcumin (CUR)-chrysin (CHR)-loaded copper (Cu) metal-organic framework (MOF) was successfully synthesized in this study. A high percentage of encapsulation efficiency (99.2%) of CUR and CHR in Cu-MOF-CUR-CHR was yielded. Other than the confirmation of the successful fusion of MOFs with CUR-CHR in CS-GL/Cu-MOF-CUR-CHR nanofibers using Fourier-transform infrared (FTIR) spectroscopy, the scanning electron microscopy (SEM) images depicted an average diameter in the range of 302-380 nm. The percentage of cumulative drug release of CS-GL/20% Cu-MOF-CUR-CHR nanofibers in phosphate-buffered solution at pH 7.4 after 48 h was 98.9%, which was higher than CS-GL/CUR-CHR nanofibers without Cu-MOFs. In the cytotoxicity test on Human epidermal keratinocytes cell line cells, it was noticed that 1% and 5% CS-GL/Cu-MOF-CUR-CHR nanofibers exhibited high cell survival (>90%). Through the colony counting method, the logarithm reduction values (LRVs) of CS-GL/5% Cu-MOF-CUR-CHR nanofibers were 2.69 against Staphylococcus aureus and 1.87 against Pseudomonas aeruginosa. It was noteworthy that the CS-GL/Cu-MOF-CUR-CHR nanofiber exhibited a higher antibacterial activity against Gram-positive than Gram-negative bacteria. Overall, the biocompatible CS-GL/Cu-MOF-CUR-CHR nanofibers with an effective antibacterial effect have the potential to be used as an alternative to antibiotics in antibacterial wound dressing applications.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.